Pandemics move in days.
Drug discovery took years.
COVID-19 killed millions before effective treatments reached patients. The bottleneck was not biology — the virus was sequenced within days. The bottleneck was the time to screen, filter, and validate compounds against the target. 22Rx runs that screen at 13.2 million compounds per second. A complete therapeutic portfolio against a novel pathogen in hours, not years.
13.2M
Compound screens per second
6 min
COVID treatments found (Paxlovid + Remdesivir)
60%
H5N1 case fatality rate — no approved treatment
Every tier-1 biodefense threat.
Complete drug portfolios.
| Pathogen | Current Status | 22Rx Approach | Mechanism |
|---|---|---|---|
| H5N1 Avian Influenza | No approved treatment. Oseltamivir partial. | HA-fusion inhibitors | Novel — no resistance possible |
| Anthrax (B. anthracis) | Ciprofloxacin + antitoxin | LF protease inhibitors | Toxin neutralization |
| Plague (Y. pestis) | Streptomycin (resistance risk) | Type III secretion blockers | Virulence disruption |
| Smallpox (Variola) | Tecovirimat only | Viral polymerase inhibitors | Replication block |
| Ebola / Marburg | mAbs — IV only, limited supply | VP40 matrix protein blockers | Budding inhibition |
| Novel pathogen (day zero) | Years | Hours | Sequence → screen → candidate |
Not just discovery.
Deployable anywhere.
01
Sequence-to-Screen
Pathogen sequence received → target protein modeled → compound library screened. No human intervention required between sequence receipt and hit list delivery.
02
Multi-Pathogen Parallel
Screen against multiple threat organisms simultaneously. One lock-free compute cluster handles concurrent screens without performance degradation.
03
Resistance Prediction
LoNC models mutation escape pathways before treatment begins. Pre-designed second and third-line compounds ready before resistance emerges.
04
Field Hardware
Runs on commodity CPU hardware. No GPU, no specialized equipment. Forward operating base with a standard server can run the full screening pipeline.
Every threat class.
Bacteria. Virus. Toxin.
H5N1 / H7N9 pandemic influenza
SARS-CoV-3 (future) pandemic preparedness
Anthrax BARDA Cat A
Plague BARDA Cat A
Smallpox BARDA Cat A
Ebola / Marburg BARDA Cat A
Botulinum toxin weaponizable
VX / Novichok antidotes nerve agents
Drug-resistant TB MDR / XDR
MRSA / CRE hospital superbugs